Home
Encodia

Encodia Market Share Analysis for June 2026

We’re a team built on diversity, skill, and a passion for creating breakthroughs that radically improve lives. We prize collaboration and always support one another to innovate, develop, and grow.

Industry: N/A

Domainencodia.com

Year Founded2015

Employees51 - 200

Annual Revenue$5M - $10M

Encodia

Encodia (including company regionals)

encodia.com

See more website traffic and engagement information

Encodia Revenue up to June 2026 is 5M - 10M

revenue generated by Encodia top domains

Encodia top domains revenue over 3 years

Revenue for Encodia top domains

encodia.com5M - 10M

See more with Sales Intelligence

Total visits to Encodia's top domains

Understand Encodia market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Encodia's top domains

Analyze Encodia engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Encodia's top domains

See how Encodia keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Encodia top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Encodia

These are the website technologies, by industry, used by Encodia top domains

Content Management System (2)

Weebly

Conversion & Analytics (2)

Google Analytics

Mobile (2)

Meta Viewport

Advertising (1)

PubMatic

More Technologies

6

See all

News & Signals from Encodia

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsEncodia, Inc. hires Nigel Beard.Encodia, a privately held biotech company developing next-generation solutions for proteomics research, announced the hiring of Nigel Beard, Ph.D., as Chief Technology Officer (CTO).

NewsEncodia, Inc. received financing of $75M in Series C on Jan 29th '21.Encodia, a privately held biotech company developing next-generation solutions for proteomics research, announced the closing of a $75 million Series C financing led by Northpond Ventures and Deerfield Management, joined by GV, Alexandria Venture Investments, and existing investors ARCH Venture Partners, Biomatics Capital, Decheng Capital, Tao Capital Partners, and Nan Fung Life Sciences.